2022. A nitric oxide-donor pravastatin hybrid drug exerts antiplatelet and antiatherogenic activity in mice. Bleeding, Thrombosis and Vascular Biology. 1, 2 (May 2022). DOI:https://doi.org/10.4081/btvb.2022.19.